v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Assets    
Cash and cash equivalents $ 130,384 $ 105,525
Restricted cash 79,470 93,409
Loans receivable at fair value 2,771,836 2,874,092
Capitalized software and other intangibles, net 69,412 71,698
Right of use assets - operating 10,486 9,441
Other assets 105,950 103,691
Total assets 3,167,538 3,257,856
Liabilities    
Secured financing 212,465 199,384
Asset-backed notes at fair value 194,339 263,799
Asset-backed borrowings at amortized cost 2,154,405 2,192,649
Corporate financing 145,053 143,663
Lease liabilities 11,389 11,468
Other liabilities 53,604 56,811
Total liabilities 2,771,255 2,867,774
Stockholders' equity    
Common stock, $0.0001 par value - 1,000,000,000 shares authorized at March 31, 2026 and December 31, 2025; 45,874,814 shares issued and 45,602,791 shares outstanding at March 31, 2026; 44,709,065 shares issued and 44,437,042 shares outstanding at December 31, 2025 8 8
Common stock, additional paid-in capital 627,524 623,668
Accumulated deficit (224,940) (227,285)
Treasury stock at cost, 272,023 shares at March 31, 2026 and December 31, 2025 (6,309) (6,309)
Total stockholders’ equity 396,283 390,082
Total liabilities and stockholders' equity $ 3,167,538 $ 3,257,856

Source

HTML PDF
XBRL
ZIP